You are invited to listen to Episode 85 of Greenberg Traurig's Trade Secret Law Evolution Podcast, "2025 Year in Review."

The First Circuit recently addressed a critical question in trade secret litigation: who actually owns a trade secret and therefore has the legal standing to sue for its misappropriation? This episode examines the court's analysis of ownership issues and the implications for companies seeking to protect their confidential information through legal action.

Greenberg Traurig launches a new podcast subseries featuring industry leaders discussing trade secret protection and competitive advantage from a business perspective. The inaugural episode features Joe Perez, co-founder of Tastemade and LIVESTRONG.COM, sharing insights on safeguarding proprietary information in the digital media and technology sectors.

The rapid advancement of artificial intelligence is fundamentally transforming trade secret litigation, making reverse engineering easier while simultaneously complicating traditional legal definitions of proprietary information. Courts in 2025 demonstrated heightened skepticism toward broad trade secret claims, requiring unprecedented specificity in identifying protected information.

On June 9, 2026, in Rondout Group Advisors, LLC v. Fresh American, LLC, the Massachusetts Appeals Court vacated summary judgment entered in favor of the plaintiffs on their Chapter 93A, Section 11 claim...

Four major fragrance manufacturers face allegations of price-fixing in a consolidated class action, with companies that purchased fragrance ingredients between 2018 and 2023 potentially having claims. Following a partial settlement by IFF for $44 million, affected purchasers must decide whether to remain in the settlement class or opt out to pursue individual claims.

Will Wagner joins hosts Adil Khan and Greg Nylen for a discussion on consumer claims related to chemical litigation, specifically focusing on false advertising and the nuances of Prop 65 enforcement in California.

Frank Citera joins host Greg Nylen for a discussion of public nuisance claims, which have taken center stage in mass tort actions.

The District of Massachusetts continues to refine the contours of conduct occurring "primarily and substantially" within the Commonwealth...

Richard A. Rosenbaum authored an article titled "Big Law Leader: 'Stay True to Foundational Principles'" in The American Lawyer.

In this inaugural episode of the "Building the Blueprint" podcast miniseries, Jaret Davis, Senior Vice President of Greenberg Traurig and Co-Managing Shareholde...

In this episode of GeTin' SALTy, host Nikki Dobay is joined by Alan Pasetsky, Tax Policy Advisor for the Global Business Alliance (GBA), for a discussion on an article...

In this episode of GeTin' SALTy, host Nikki Dobay is joined by Marilyn Wethekam, Of Counsel with the Council On State Taxation, for a discussion of the Supreme Court's recent decision in Loper Bright Enterprises...

In this episode of GeTin' SALTy, host Nikki Dobay is once again joined by Jeff Newgard, principal at Peak Policy, for a discussion about the Portland tax system and the city's charter authority.

In this episode of the GeTin' SALTy podcast, host Nikki Dobay is once again joined by Jared Walczak, Vice President of Special Projects at the Tax Foundation...

In part 3 of the Building the Blueprint podcast miniseries, host Jaret Davis, Senior Vice President of Greenberg Traurig and Co-Managing Shareholder of the Miami office...

GT eDiscovery & eRetention Practice Shareholder Jacqueline Tambone deGrandpre and Of Counsel Kelly M. Pesce will participate in the "2024 Year in Review: eDiscovery and Artificial Intelligence" event hosted

Greenberg Traurig Shareholder Reena Bajowala has been named Vice-Chair and Chairperson-Elect of the Cybersecurity and Technology Law Committee...

May 23, 2024, the SEC approved the first investment products linked to the price of Ether for listing and trading on three exchanges, following approval of the first Bitcoin ETFs earlier this year.

The healthtech industry is witnessing fierce competition as companies develop AI-powered tools for clinical decision support, robotic surgery, medical imaging, and drug discovery.